Work

Survival Disparity Between Antiviral-Treated and Antiviral-Naïve Patients Who Develop Their First HBV-Associated Hepatocellular Carcinoma

Year: 2021

Type: article

Abstract: Hepatitis B virus (HBV) infection remains a public health burden resulting in over 50% of cases of hepatocellular carcinoma (HCC) worldwide. Despite successful HBV suppression with antiviral therapy, there is persistent risk for HCC development in HBV patients and lack of long-term longitudinal assessment

Source: Archives of Gastroenterology Research

DOI: 10.33696/gastroenterology.2.033

Authors: Daniel Garrido, Peter Block, Selena Lin, Dina Halegoua-DeMarzio, Hie-Won Hann

Language: English

Topic: Hepatitis B Virus Studies

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: hybrid

OpenAlex ID: W4200484541

FWCI: 0.911

Cites:

Cited by: 6

Related to: 10